New indication based on results from a global Phase 3 trial demonstrating significantly improved overall survival benefit for PD-L1 positive patients treated with TEVIMBRA in...
Danish biotech replaces 1980s cell-based methods with revolutionary cell-free technology, making gene therapy more accessible. Innovative approach allows for unprecedented quality in hours rather than...
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical...
On Broadway Avenue in Everett’s core, the future of behavioral health is taking shape. Phase II of Compass Health’s Broadway Campus Redevelopment is nearing completion,...
Patent Term Adjustment will provide market exclusivity in the United States into 2040 for all therapeutic indications OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology...
Leading AI-driven dynamic decision intelligence platform to enhance network visibility and accelerate decision-making ParkourSC, a leader in AI-driven supply chain dynamic decision intelligence solutions, announced...
Proprietary safety features support advanced therapies across a wide range of patients and ease the burden on caregivers Agiliti, a leading manufacturer and provider of...
Turacoz highlights the growing integration of AI, human insight, and patient involvement in medical communications, while emphasizing the importance of integrity and transparency. With the...
Marks significant expansion of initiative to help health systems access critical, at-risk medications for patients Cencora, a global healthcare company, has significantly expanded the number...
GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A...